Topics Webinar | Upper Aerodigestive Tract Cancer: Head and Neck Squamous Cancer
Welcome from the Chair
Topics Webinar
Upper Aerodigestive Tract Cancer: Head and Neck Squamous Cancer
Upper aerodigestive tract cancer (UATC) is aggressive malignancy derived from stratified epithelium of the upper aerodigestive tract, including oral cavity, larynx and oropharynx, and esophagus. Over one million new cases of UATC are diagnosed worldwide every year, with oral and esophageal cancers being the most common types. Human papillomavirus (HPV)-positive and -negative tumors are considered distinct diseases with distinguishing biological and clinical features. Effective targeted regimens are still unavailable for most UATC, which is highly aggressive. For example, 5-year survival rate of oral cancer patients is approximately 50%. Conventional cytotoxic chemotherapeutic options for oral cancer patients are limited and often ineffective. More importantly, the short-term effects (e.g., mucositis, odynophagia) and long-term toxicities (e.g., xerostomia, dysphagia, ototoxicity) from treatment substantially affect quality of life and rival the impact of the cancer itself. This webinar aims to highlight the latest advances in both basic and clinical studies on UATC, with the goal of promoting research of pathophysiology of UATC to advance the healthcare and life quality of its patients.
Date: 19 January 2023
Time: 1:00 am CET (19 January 2023) | 7:00 pm EST (18 January 2023) | 4:00 pm PST (18 January 2023)
Webinar ID: 842 4832 1038
Chair
Center for Craniofacial Molecular Biology, University of Southern California, USA
Dr. Dechen Lin is Assistant Professor and faculty at the Center for Craniofacial Molecular Biology, University of Southern California. He is also a faculty member at USC Norris Comprehensive Cancer Center as well as the Department of Biochemistry and Molecular Medicine. Dr. Lin’s research background is cancer genomics and epigenomics, with training and expertise in both experimental and computational biology. He directs an NCI-funded laboratory, and the major interest of his work is investigating genomic and epigenomics abnormalities in upper aerodigestive tract cancers, including head and neck as well as esophageal cancers. Dr. Lin has published ninety-five research papers in cancer biology and genomics, with many appearing in influential journals such as Nature Genetics, Science Translational Medicine, Nature Communications, Gastroenterology, GUT, PNAS, Blood, etc. Moreover, he has developed novel mathematical methods and computational pipelines for the analyses of genomic and epigenomic data. The findings presented in these articles have been cited more than 7,700 times, and he has an h-index of 42. Dr Lin has mentored more than thirty Ph.D. students and postdoc fellows over the years.
Invited Speakers
Department of Otolaryngology–Head and Neck Surgery, Vanderbilt University, USA
Dr. Eben Rosenthal is a surgeon-scientist and academic leader who brings extensive leadership experience to Vanderbilt. He serves as Professor and Chair of the Department of Otolaryngology–Head and Neck Surgery and holds the Carol and John S. Odess Chair in Facial Plastic and Reconstructive Surgery. In his previous position, he was the John and Ann Doerr Medical Director and Associate Director of Clinical Care with Stanford Cancer Center. Prior to his tenure at Stanford, he was division director of Otolaryngology–Head and Neck Surgery and held the John S. Odess Endowed Chair at the University of Alabama Birmingham. He specializes in the treatment and reconstruction of head and neck cancer. His research interests involve the use of optical imaging techniques to better detect cancer during surgical procedures, and he has initiated multiple clinical trials in improving cancer surgery and assessing drug delivery. A mentor and frequently invited speaker, Rosenthal has authored or co-authored more than 250 peer-reviewed publications
Dr. Allen Ho is Professor of Surgery at Cedars-Sinai. He serves as Director of the Head and Neck Cancer Program. His research focuses on the treatment of head and neck tumors, including HPV+ oropharynx cancers and thyroid malignancies.
Department of Otolaryngology–Head and Neck Surgery, University of Southern California, USA
Dr. Sinha is the Medical Director of the USC Head and Neck Center and the Watt Family Endowed Chair for Head and Neck Cancers. Dr Sinha’s research focus is advancing early detection of cancer, using liquid biopsy, and the rehabilitation of speech and swallowing, using real-time MRI. his research interests also include reconstructive surgery and robotic surgery.
Webinar Content
Program
|
Speaker/Presentation theme |
Time in CET (19 Jan) |
Time in PST (18 Jan) |
|
Professor Eben Rosenthal Molecular Imaging of Head and Neck Cancer |
1:00 - 1:30 am |
4:00 - 4:30 pm |
|
Professor Allen Ho HPV + Oropharynx Cancers |
1:30 - 3:00 am |
4:30 - 5:00 pm |
|
Professor Uttam Sinha Survivorship and Rehabilitation of Head and Neck Cancer Patients |
2:00 - 2:30 am |
5:00 - 5:30 pm |
|
Professor De-Chen Lin Epigenomic Research on Head and Neck Cancer |
2:30 - 3:00 am |
5:30 - 6:00 pm |
Relevant Topic
Abstract submission deadline: 20 September 2023
Sponsors and Partners
Organizers
